208 related articles for article (PubMed ID: 27530723)
41. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
42. Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature.
Nord KM; Kandel J; Lefkowitch JH; Lobritto SJ; Morel KD; North PE; Garzon MC
Pediatrics; 2006 Sep; 118(3):e907-13. PubMed ID: 16880251
[TBL] [Abstract][Full Text] [Related]
43. [Corticosteroid therapy of hemangiomas in children (literature survey)].
Zav'ialov PV; Gasanov DG
Khirurgiia (Mosk); 1975 Aug; (8):127-9. PubMed ID: 1102762
[No Abstract] [Full Text] [Related]
44. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
45. Failure of intralesional propranolol in infantile hemangiomas.
Torres-Pradilla M; Baselga E
Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
[TBL] [Abstract][Full Text] [Related]
46. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
47. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
Lie E; Püttgen KB
Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
[TBL] [Abstract][Full Text] [Related]
48. [Propranolol for the treatment of severe hemangiomas of infancy: results from a series of 28 patients].
Bernabeu-Wittel J; Pereyra-Rodríguez JJ; Mantrana-Bermejo ME; Fernández-Pineda I; de Agustín JC; Conejo-Mir J
Actas Dermosifiliogr; 2011 Sep; 102(7):510-6. PubMed ID: 21514550
[TBL] [Abstract][Full Text] [Related]
49. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
50. Local steroid therapy in cutaneous hemangiomas.
Gangopadhyay AN; Sharma SP; Gopal SC; Gupta DK; Panjawani K; Sinha JK
Indian Pediatr; 1996 Jan; 33(1):31-3. PubMed ID: 8772948
[TBL] [Abstract][Full Text] [Related]
51. A new treatment with bleomycin for complicated cutaneous hemangioma in children.
Sarihan H; Mocan H; Yildiz K; Abes M; Akyazici R
Eur J Pediatr Surg; 1997 Jun; 7(3):158-62. PubMed ID: 9241503
[TBL] [Abstract][Full Text] [Related]
52. Color Doppler Ultrasound Follow-Up of Infantile Hemangiomas and Peripheral Vascularity in Patients Treated with Propranolol.
Kutz AM; Aranibar L; Lobos N; Wortsman X
Pediatr Dermatol; 2015; 32(4):468-75. PubMed ID: 25940359
[TBL] [Abstract][Full Text] [Related]
53. Impact of Screening for Hepatic Hemangiomas in Patients with Multiple Cutaneous Infantile Hemangiomas.
Rialon KL; Murillo R; Fevurly RD; Kulungowski AM; Zurakowski D; Liang M; Kozakewich HP; Alomari AI; Fishman SJ
Pediatr Dermatol; 2015; 32(6):808-12. PubMed ID: 26223454
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.
Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C
Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995
[TBL] [Abstract][Full Text] [Related]
55. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of intralesional corticosteroid application for hemangiomas.
Emir S; Gürlek Gökçebay D; Demirel F; Tunç B
Turk J Med Sci; 2015; 45(2):335-8. PubMed ID: 26084124
[TBL] [Abstract][Full Text] [Related]
57. Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition.
Braun M; Metry D; Frieden IJ; Antaya RJ; Mancini AJ; Kohn LL
Pediatr Dermatol; 2021 Sep; 38(5):1061-1065. PubMed ID: 34339535
[TBL] [Abstract][Full Text] [Related]
58. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas.
Koay AC; Choo MM; Nathan AM; Omar A; Lim CT
J Ocul Pharmacol Ther; 2011 Jun; 27(3):309-11. PubMed ID: 21542771
[TBL] [Abstract][Full Text] [Related]
59. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
